Table 1.
Baseline demographic and clinical characteristics of cancer survivors included in the app-based stress management intervention (N = 25)
| Characteristics | Cancer survivors (N = 25) | |||
|---|---|---|---|---|
| Median | Range | n | % | |
| Age (years) | 46 | 34–71 | ||
| Months since diagnosis | 18 | 0.5–78 | ||
| Gender | ||||
| Female | 21 | 84 | ||
| Male | 4 | 16 | ||
| Marital status | ||||
| Married/cohabitating | 18 | 84 | ||
| Single/divorced | 7 | 16 | ||
| Education | ||||
| Elementary/high school | 5 | 20 | ||
| University/college ≤4 years | 8 | 32 | ||
| University/college >4 years | 12 | 48 | ||
| Employment status | ||||
| Full-time/part-time work | 8 | 32 | ||
| Sick leave/disability benefits | 14 | 56 | ||
| Retired/other | 3 | 12 | ||
| Diagnosis | ||||
| Breast cancer | 10 | 40 | ||
| Othera (see below) | 15 | 60 | ||
| Metastatic disease | ||||
| Yes | 8 | 32 | ||
| No | 17 | 68 | ||
| Treatment | ||||
| Operation | 18 | 72 | ||
| Chemotherapy | 16 | 64 | ||
| Hormone therapy | 10 | 40 | ||
| Radiation | 9 | 36 | ||
| Immune therapy | 1 | 4 |
aOther includes: cancer of bladder, cervix, ovary, fallopian tube, colon, pancreas, peritoneal, lung, prostate, endometriosis sarcoma, melanoma, chronic myelogenous leukemia, leukemia, and brain tumor.